share_log

Ensysce Biosciences Regains Full Nasdaq Compliance

Ensysce Biosciences Regains Full Nasdaq Compliance

Ensysce Biosciences 恢復完全的納斯達克合規性
Benzinga ·  2024/12/23 21:21

Meeting Minimum Bid Price And Stockholders' Equity Requirements; Common Stock To Continue Trading On Nasdaq Capital Market

滿足最低買盤價格和股東權益要求;普通股將在納斯達克資本市場繼續交易

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論